- Home
- PSHG vs DYAI Comparison
PSHG vs DYAI Comparison
Compare PSHG & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSHG | DYAI |
|---|---|---|
| Founded | 2010 | 1979 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1M | 17.0M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PSHG | DYAI |
|---|---|---|
| Price | $1.83 | $0.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 63.5K | ★ 192.2K |
| Earning Date | 05-26-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | $49.57 | $122.79 |
| Revenue Next Year | $2.73 | $100.00 |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.61 | $0.34 |
| 52 Week High | $2.58 | $1.60 |
Technical Indicators
Market Signals| Indicator | PSHG | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 25.71 |
| Support Level | $1.66 | N/A |
| Resistance Level | $1.91 | $0.90 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 51.68 | 30.35 |
Price Performance
Historical ComparisonAbout PSHG Performance Shipping Inc.
Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.